Core Viewpoint - The company, Shanghai Rongtai Health Technology Co., Ltd., has announced its expected daily related transactions for the year 2026, which will not require shareholder approval and are deemed to not affect the company's independence or harm shareholder interests [2][3][4]. Group 1: Daily Related Transactions Overview - The board of directors approved the expected daily related transactions for 2026 on February 6, 2026, with a unanimous vote of 6 in favor and no abstentions or oppositions [3][4]. - Independent directors reviewed and approved the proposal, confirming that the expected transactions are necessary for daily operations and comply with market pricing principles [3][4]. - The audit committee also endorsed the proposal, stating that the transactions align with the interests of the company and its shareholders, ensuring no impact on the company's independence [4]. Group 2: Expected Transaction Amounts and Categories - The total expected amount for daily related transactions in 2026 is 69.70 million yuan (approximately 6,970.27 thousand yuan) [6]. - The transactions are based on market prices and are structured to ensure fairness and transparency, with contracts already signed with related parties for the year [8]. Group 3: Related Parties and Transaction Purpose - The related parties involved include Jiaxing Ouyuan Motor Co., Ltd. and Suzhou Shangse Metal Products Co., Ltd., both of which are operational and have strong performance records [8]. - The transactions are essential for the company's normal business operations and are expected to facilitate the execution of daily business activities without compromising the interests of shareholders [8].